Yale Pathology Annual CME Conference Featuring Gastrointestinal Pathology

The Yale Gastrointestinal Pathology CME course, led by faculty from the Department of Pathology at Yale School of Medicine, offers a broad overview of many areas of gastrointestinal, pancreatic, and hepatobiliary pathology. Aimed at both academic and community practicing pathologists at all expertise levels, as well as in-training residents and fellows, the course provides updates on advances in gastrointestinal, pancreatic, and hepatobiliary pathology, including updates from the 5th edition of the WHO classification of digestive tumors, and aids in developing diagnostic strategies in recognizing diverse morphologic features. Additionally, the course addresses the prudent selection of appropriate ancillary immunohistochemical and molecular markers, along with rational panels for diagnosis. Interactive learning formats, including didactic lectures and whole slide digital imaging case discussions covering differential diagnosis, clinical implications and the appropriate utilization of ancillary tests will be integrated into the course. By actively participating in these formats, participants will gain valuable strategies applicable to their daily clinical practice, ultimately leading to enhanced diagnostic accuracy and improved patient care.

LEARNING OBJECTIVES

• Gain competency in applying new diagnostic criteria and disease classifications.
• Gain competency in using ancillary studies to achieve accurate diagnosis.
• Become proficient in apply morphologic criteria in correlation with clinical findings for accurate pathology reporting.
• Learn strategies to avoid mismanagement and to enhance communication with clinical teams to ensure optimal patient care.

Accreditation Statement

Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Yale School of Medicine designates this Live Activity for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Financial Relationships Statement

Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.